Thermo Fisher Scientific Inc. (NYSE:TMO) – Equities researchers at KeyCorp reduced their Q3 2016 earnings per share (EPS) estimates for Thermo Fisher Scientific in a research note issued on Sunday. KeyCorp analyst M. Mishan now anticipates that the brokerage will post earnings of $1.96 per share for the quarter, down from their prior estimate of $1.97. KeyCorp also issued estimates for Thermo Fisher Scientific’s Q4 2016 earnings at $2.42 EPS, FY2016 earnings at $8.21 EPS and FY2017 earnings at $9.33 EPS.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings data on Thursday, July 28th. The company reported $2.03 earnings per share for the quarter, beating analysts’ consensus estimates of $2.01 by $0.02. The firm earned $4.54 billion during the quarter, compared to analysts’ expectations of $4.50 billion. Thermo Fisher Scientific had a net margin of 11.35% and a return on equity of 14.70%. The business’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.84 earnings per share.

Earnings History and Estimates for Thermo Fisher Scientific (NYSE:TMO)

Other analysts also recently issued research reports about the stock. Jefferies Group reissued a “hold” rating on shares of Thermo Fisher Scientific in a research report on Thursday, August 4th. BTIG Research raised shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating and set a $180.00 price objective for the company in a research report on Friday, July 22nd. Goldman Sachs Group Inc. reaffirmed a “buy” rating on shares of Thermo Fisher Scientific in a research report on Wednesday, July 6th. Zacks Investment Research downgraded shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Friday, August 5th. Finally, Mizuho set a $175.00 price objective on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a research report on Thursday, July 28th. Three analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $162.72.

Shares of Thermo Fisher Scientific (NYSE:TMO) traded down 2.43% on Tuesday, hitting $155.24. 1,020,363 shares of the company were exchanged. Thermo Fisher Scientific has a 52-week low of $119.75 and a 52-week high of $160.68. The firm has a market cap of $61.21 billion, a P/E ratio of 31.05 and a beta of 0.97. The company has a 50-day moving average price of $153.48 and a 200 day moving average price of $150.87.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 28,797 shares of the firm’s stock in a transaction on Friday, September 2nd. The stock was sold at an average price of $151.01, for a total value of $4,348,634.97. Following the sale, the chief executive officer now directly owns 307,444 shares in the company, valued at $46,427,118.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Marc N. Casper sold 30,000 shares of the firm’s stock in a transaction on Thursday, September 1st. The shares were sold at an average price of $151.17, for a total value of $4,535,100.00. Following the completion of the sale, the chief executive officer now owns 308,647 shares in the company, valued at $46,658,166.99. The disclosure for this sale can be found here. 0.52% of the stock is owned by company insiders.

A number of large investors have recently bought and sold shares of TMO. Emerald Acquisition Ltd. bought a new stake in Thermo Fisher Scientific during the second quarter worth about $200,618,000. Wellington Management Group LLP boosted its stake in shares of Thermo Fisher Scientific by 26.0% in the first quarter. Wellington Management Group LLP now owns 6,135,669 shares of the company’s stock worth $868,749,000 after buying an additional 1,267,967 shares in the last quarter. Sound Shore Management Inc. CT boosted its stake in shares of Thermo Fisher Scientific by 123.5% in the second quarter. Sound Shore Management Inc. CT now owns 2,204,253 shares of the company’s stock worth $138,096,000 after buying an additional 1,217,950 shares in the last quarter. FMR LLC boosted its stake in shares of Thermo Fisher Scientific by 11.3% in the second quarter. FMR LLC now owns 8,216,645 shares of the company’s stock worth $1,214,093,000 after buying an additional 834,858 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its stake in shares of Thermo Fisher Scientific by 72.3% in the first quarter. JPMorgan Chase & Co. now owns 1,953,935 shares of the company’s stock worth $276,658,000 after buying an additional 820,110 shares in the last quarter. Institutional investors own 87.38% of the company’s stock.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

5 Day Chart for NYSE:TMO

Receive News & Stock Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related stocks with our FREE daily email newsletter.